Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Zadra G, Ribeiro CF, Chetta P, Ho Y, Cacciatore S, Gao X, et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2019;116(2):631-640.

Stopsack KH, Whittaker CA, Gerke TA, Loda M, Kantoff PW, Mucci LA, et al. Aneuploidy drives lethal progression in prostate cancer. Proc Natl Acad Sci U S A. 2019;116(23):11390-11395.

Nakanishi Y, Diaz-Meco MT, Moscat J. Serrated Colorectal Cancer: The Road Less Travelled? Trends Cancer. 2019;5(11):742-754.

Patel KR, Taylor BL, Khani F, Guzzo TJ, Scherr DS, Ravishankar R, et al. Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer. Urology. 2019;131:150-156.

Ji G, Xu R, Niu Y, Li N, Ivashkiv L, Bostrom MP, et al. Vascular endothelial growth factor pathway promotes osseointegration and CD31EMCN endothelium expansion in a mouse tibial implant model: an animal study. Bone Joint J. 2019;101-B(7_Supple_C):108-114.

Cushing MM, Asmis LM, Harris RM, DeSimone RA, Hill S, Ivascu N, et al. Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro. Transfusion. 2019;59(5):1818-1826.

Xu G, Zheng H, Li JY. Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component. Brain Tumor Pathol. 2019;36(3):129-134.

Makhni MC, Zhang Y, Park PJ, Cerpa M, Yang M, Pham MH, et al. The "kickstand rod" technique for correction of coronal imbalance in patients with adult spinal deformity: initial case series. J Neurosurg Spine. 2019:1-8.

DeSimone RA, Ong SJ, Crowley KM, Vasovic LV, Senaldi E, Kessler DA, et al. Hereditary elliptocytosis of donor red blood cell unit detected during Coombs crossmatch. Transfusion. 2019;59(2):446-447.

Musselman K, Glynn S, Mosquera JM, Elemento O, Sboner A, Beltran H, et al. Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma. Gynecol Oncol Rep. 2019;28:54-57.